These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 25752887

  • 1. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.
    Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ.
    J Physiol Biochem; 2015 Jun; 71(2):341-9. PubMed ID: 25752887
    [Abstract] [Full Text] [Related]

  • 2. Omega-3 fatty acids and inflammatory processes: from molecules to man.
    Calder PC.
    Biochem Soc Trans; 2017 Oct 15; 45(5):1105-1115. PubMed ID: 28900017
    [Abstract] [Full Text] [Related]

  • 3. Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis.
    Souza PR, Norling LV.
    Eur J Pharmacol; 2016 Aug 15; 785():165-173. PubMed ID: 26165764
    [Abstract] [Full Text] [Related]

  • 4. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease.
    Schwanke RC, Marcon R, Bento AF, Calixto JB.
    Eur J Pharmacol; 2016 Aug 15; 785():156-164. PubMed ID: 26325092
    [Abstract] [Full Text] [Related]

  • 5. Novel chemical mediators in the resolution of inflammation: resolvins and protectins.
    Serhan CN.
    Anesthesiol Clin; 2006 Jun 15; 24(2):341-64. PubMed ID: 16927933
    [Abstract] [Full Text] [Related]

  • 6. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
    Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B.
    Prostaglandins Other Lipid Mediat; 2012 Mar 15; 97(3-4):73-82. PubMed ID: 22326554
    [Abstract] [Full Text] [Related]

  • 7. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
    Nowak JZ.
    Postepy Hig Med Dosw (Online); 2010 Mar 17; 64():115-32. PubMed ID: 20354260
    [Abstract] [Full Text] [Related]

  • 8. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
    Serhan CN, Gotlinger K, Hong S, Arita M.
    Prostaglandins Other Lipid Mediat; 2004 Apr 17; 73(3-4):155-72. PubMed ID: 15290791
    [Abstract] [Full Text] [Related]

  • 9. Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis.
    Maskrey BH, Megson IL, Rossi AG, Whitfield PD.
    Mol Nutr Food Res; 2013 Aug 17; 57(8):1390-400. PubMed ID: 23417926
    [Abstract] [Full Text] [Related]

  • 10. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
    Capó X, Martorell M, Busquets-Cortés C, Tejada S, Tur JA, Pons A, Sureda A.
    Eur J Med Chem; 2018 Jun 10; 153():123-130. PubMed ID: 28732558
    [Abstract] [Full Text] [Related]

  • 11. Long-chain fatty acids and inflammation.
    Calder PC.
    Proc Nutr Soc; 2012 May 10; 71(2):284-9. PubMed ID: 22369781
    [Abstract] [Full Text] [Related]

  • 12. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance.
    Poorani R, Bhatt AN, Dwarakanath BS, Das UN.
    Eur J Pharmacol; 2016 Aug 15; 785():116-132. PubMed ID: 26335394
    [Abstract] [Full Text] [Related]

  • 13. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
    Kwon Y.
    Mol Nutr Food Res; 2020 Feb 15; 64(4):e1900824. PubMed ID: 31797565
    [Abstract] [Full Text] [Related]

  • 14. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance.
    Calder PC.
    Biochim Biophys Acta; 2015 Apr 15; 1851(4):469-84. PubMed ID: 25149823
    [Abstract] [Full Text] [Related]

  • 15. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
    Molfino A, Amabile MI, Monti M, Muscaritoli M.
    Oxid Med Cell Longev; 2017 Apr 15; 2017():5987082. PubMed ID: 28694914
    [Abstract] [Full Text] [Related]

  • 16. [Resolvins: new derivates of fatty acids, polyunsaturated (omega-3) with therapeutic potential in inflammatory intestinal diseases].
    Maillard MH.
    Rev Med Suisse; 2006 Nov 15; 2(87):2634-5. PubMed ID: 17343155
    [No Abstract] [Full Text] [Related]

  • 17. Omega-3 polyunsaturated fatty acids inhibit the increase in cytokines and chemotactic factors induced in vitro by lymph fluid from an intestinal ischemia-reperfusion injury model.
    Zhang R, He GZ, Wang YK, Zhou KG, Ma EL.
    Nutrition; 2015 Mar 15; 31(3):508-14. PubMed ID: 25701342
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease.
    Yates CM, Calder PC, Ed Rainger G.
    Pharmacol Ther; 2014 Mar 15; 141(3):272-82. PubMed ID: 24201219
    [Abstract] [Full Text] [Related]

  • 19. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids.
    Wall R, Ross RP, Fitzgerald GF, Stanton C.
    Nutr Rev; 2010 May 15; 68(5):280-9. PubMed ID: 20500789
    [Abstract] [Full Text] [Related]

  • 20. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.
    Seki H, Tani Y, Arita M.
    Prostaglandins Other Lipid Mediat; 2009 Sep 15; 89(3-4):126-30. PubMed ID: 19737659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.